ICD-10-CM Billable Code

E09.354

Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code E09.354 refers to a form of diabetes caused by certain drugs or chemicals. This condition is compounded by severe eye problems, including proliferative diabetic retinopathy along with different types of retinal detachment. These eye issues can lead to vision impairment if not properly managed. Recognizing this condition involves understanding its causes, symptoms, diagnosis, and potential treatments.

Causes & Symptoms

Clinical Causes: Use of certain medications or exposure to specific chemicals that can trigger diabetes. Prolonged or high-dose medication intake that impacts blood sugar regulation. Pre-existing conditions that may be worsened or triggered by chemical or drug exposure.

Key Symptoms: Sudden or gradual loss of vision. Blurred vision or spots floating in the field of view. Signs of retinal detachment such as flashing lights or a curtain-like shadow over part of the visual field. Symptoms of high blood sugar, including increased thirst, frequent urination, and fatigue.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a comprehensive eye examination, including retinal imaging like optical coherence tomography (OCT) and fluorescein angiography, to identify proliferative diabetic retinopathy and retinal detachments. Blood tests may also be performed to evaluate blood sugar levels and confirm diabetes mellitus induced by drugs or chemicals.

Treatment Protocols: Treatment strategies focus on managing blood sugar levels and addressing the eye conditions. Approaches may include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E09.354 a billable ICD-10 code?
Yes, E09.354 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E09.354?
Clinical documentation must specify the nature of Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

rhegmatogenous retinopathy proliferative traction diabetic retinal chemical mellitus detachment combined induced diabetes